{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T07:27:11Z","timestamp":1789457231491,"version":"build-2803163510"},"reference-count":131,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2021,6,7]],"date-time":"2021-06-07T00:00:00Z","timestamp":1623024000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,6,7]],"date-time":"2021-06-07T00:00:00Z","timestamp":1623024000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Gouvernement du Canada | Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["MOP\u2010142399"],"award-info":[{"award-number":["MOP\u2010142399"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Gouvernement du Canada | Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT\u2010159618"],"award-info":[{"award-number":["PJT\u2010159618"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"name":"James O. Maria Meadows Studentship"},{"name":"Maysie MacSporran Award"},{"name":"Charlotte and Leo Karassik Foundation Oncology PhD Fellowship"},{"name":"CIHR Studentship Award","award":["GSD\u2010164154"],"award-info":[{"award-number":["GSD\u2010164154"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO Mol Med"],"published-print":{"date-parts":[[2021,7,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Cachexia syndrome develops in patients with diseases such as cancer and sepsis and is characterized by progressive muscle wasting. While iNOS is one of the main effectors of cachexia, its mechanism of action and whether it could be targeted for therapy remains unexplored. Here, we show that iNOS knockout mice and mice treated with the clinically tested iNOS inhibitor GW274150 are protected against muscle wasting in models of both septic and cancer cachexia. We demonstrate that iNOS triggers muscle wasting by disrupting mitochondrial content, morphology, and energy production processes such as the TCA cycle and acylcarnitine transport. Notably, iNOS inhibits oxidative phosphorylation through impairment of complexes II and IV of the electron transport chain and reduces ATP production, leading to energetic stress, activation of AMPK, suppression of mTOR, and, ultimately, muscle atrophy. Importantly, all these effects were reversed by GW274150. Therefore, our data establish how iNOS induces muscle wasting under cachectic conditions and provide a proof of principle for the repurposing of iNOS inhibitors, such as GW274150 for the treatment of cachexia.<\/jats:p>","DOI":"10.15252\/emmm.202013591","type":"journal-article","created":{"date-parts":[[2021,6,7]],"date-time":"2021-06-07T22:18:20Z","timestamp":1623104300000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Pharmacological or genetic inhibition of iNOS prevents cachexia\u2010mediated muscle wasting and its associated metabolism defects"],"prefix":"10.1038","volume":"13","author":[{"given":"Jason","family":"Sadek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek T","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca","family":"Colalillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amr","family":"Omer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne\u2010Marie K","family":"Tremblay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie","family":"Sanguin\u2010Gendreau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Muller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Di Marco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5329-6445","authenticated-orcid":false,"given":"Marco Emilio","family":"Bianchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4758-4835","authenticated-orcid":false,"given":"Imed\u2010Eddine","family":"Gallouzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,7]]},"reference":[{"key":"BFEMMM202013591_CR1","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/00149831-200308000-00009","volume":"10","author":"V Adams","year":"2003","unstructured":"Adams V, Spate U, Krankel N, Schulze PC, Linke A, Schuler G, Hambrecht R (2003) Nuclear factor\u2010kappa B activation in skeletal muscle of patients with chronic heart failure: correlation with the expression of inducible nitric oxide synthase. Eur J Cardiovasc Prev Rehabil 10: 273\u2013277","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"BFEMMM202013591_CR2","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1136\/thx.2003.017640","volume":"59","author":"A Agusti","year":"2004","unstructured":"Agusti A, Morla M, Sauleda J, Saus C, Busquets X (2004) NF\u2010kappaB activation and iNOS upregulation in skeletal muscle of patients with COPD and low body weight. Thorax 59: 483\u2013487","journal-title":"Thorax"},{"key":"BFEMMM202013591_CR3","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1016\/j.humimm.2013.06.009","volume":"74","author":"H Ahsan","year":"2013","unstructured":"Ahsan H (2013) 3\u2010Nitrotyrosine: A biomarker of nitrogen free radical species modified proteins in systemic autoimmunogenic conditions. Hum Immunol 74: 1392\u20131399","journal-title":"Hum Immunol"},{"key":"BFEMMM202013591_CR4","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.freeradbiomed.2019.10.411","volume":"146","author":"S Anavi","year":"2019","unstructured":"Anavi S, Tirosh O (2019) iNOS as a metabolic enzyme under stress conditions. Free Radic Biol Med 146: 16\u201335","journal-title":"Free Radic Biol Med"},{"key":"BFEMMM202013591_CR5","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.bbalip.2014.03.004","volume":"1841","author":"D Antunes","year":"2014","unstructured":"Antunes D, Padr\u00e3o AI, Maciel E, Santinha D, Oliveira P, Vitorino R, Moreira\u2010Gon\u00e7alves D, Cola\u00e7o B, Pires MJ, Nunes C et al (2014) Molecular insights into mitochondrial dysfunction in cancer\u2010related muscle wasting. Biochim Biophys Acta 1841: 896\u2013905","journal-title":"Biochim Biophys Acta"},{"key":"BFEMMM202013591_CR6","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s13539-012-0067-5","volume":"3","author":"JM Argil\u00e9s","year":"2012","unstructured":"Argil\u00e9s JM, Busquets S, L\u00f3pez\u2010Soriano FJ, Costelli P, Penna F (2012) Are there any benefits of exercise training in cancer cachexia? J cachexia Sarcopenia Muscle 3: 73\u201376","journal-title":"J cachexia Sarcopenia Muscle"},{"key":"BFEMMM202013591_CR7","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1016\/j.numecd.2012.04.011","volume":"23","author":"J Argil\u00e9s","year":"2013","unstructured":"Argil\u00e9s J, L\u00f3pez\u2010Soriano F, Busquets S (2013) Mechanisms and treatment of cancer cachexia. Nutr Metab Cardiovasc Dis 23: S19\u2013S24","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"BFEMMM202013591_CR8","first-page":"221","volume":"18","author":"JM Argiles","year":"2015","unstructured":"Argiles JM, Lopez\u2010Soriano FJ, Busquets S (2015) Muscle wasting in cancer: the role of mitochondria. Curr Opin Clin Nutr Metab Care 18: 221\u2013225","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"BFEMMM202013591_CR9","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41574-018-0123-0","volume":"15","author":"JM Argiles","year":"2018","unstructured":"Argiles JM, Stemmler B, Lopez\u2010Soriano FJ, Busquets S (2018) Inter\u2010tissue communication in cancer cachexia. Nat Rev Endocrinol 15: 9\u201320","journal-title":"Nat Rev Endocrinol"},{"key":"BFEMMM202013591_CR10","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.celrep.2019.06.018","volume":"28","author":"JD Bailey","year":"2019","unstructured":"Bailey JD, Diotallevi M, Nicol T, McNeill E, Shaw A, Chuaiphichai S, Hale A, Starr A, Nandi M, Stylianou E et al (2019) Nitric oxide modulates metabolic remodeling in inflammatory macrophages through TCA cycle regulation and itaconate accumulation. Cell Rep 28: 218\u2013230","journal-title":"Cell Rep"},{"key":"BFEMMM202013591_CR11","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1017\/S0029665115002311","volume":"74","author":"C Baldwin","year":"2015","unstructured":"Baldwin C (2015) The effectiveness of nutritional interventions in malnutrition and cachexia. Proc Nutr Soc 74: 397\u2013404","journal-title":"Proc Nutr Soc"},{"key":"BFEMMM202013591_CR12","doi-asserted-by":"crossref","first-page":"17105","DOI":"10.1038\/nrdp.2017.105","volume":"4","author":"VE Baracos","year":"2018","unstructured":"Baracos VE, Martin L, Korc M, Guttridge DC, Fearon KCH (2018) Cancer\u2010associated cachexia. Nat Rev Dis Primers 4: 17105","journal-title":"Nat Rev Dis Primers"},{"key":"BFEMMM202013591_CR13","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1016\/j.febslet.2005.02.017","volume":"579","author":"E Barreiro","year":"2005","unstructured":"Barreiro E, de la Puente B, Busquets S, Lopez\u2010Soriano FJ, Gea J, Argiles JM (2005) Both oxidative and nitrosative stress are associated with muscle wasting in tumour\u2010bearing rats. FEBS Lett 579: 1646\u20131652","journal-title":"FEBS Lett"},{"key":"BFEMMM202013591_CR14","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1517\/14712598.2011.627850","volume":"11","author":"TJ Bayliss","year":"2011","unstructured":"Bayliss TJ, Smith JT, Schuster M, Dragnev KH, Rigas JR (2011) A humanized anti\u2010IL\u20106 antibody (ALD518) in non\u2010small cell lung cancer. Expert Opin Biol Ther 11: 1663\u20131668","journal-title":"Expert Opin Biol Ther"},{"key":"BFEMMM202013591_CR15","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/1471-2164-7-142","volume":"7","author":"RA van den Berg","year":"2006","unstructured":"van den Berg RA, Hoefsloot HCJ, Westerhuis JA, Smilde AK, van der Werf MJ (2006) Centering, scaling, and transformations: improving the biological information content of metabolomics data. BMC Genom 7: 142","journal-title":"BMC Genom"},{"key":"BFEMMM202013591_CR16","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/nri1004","volume":"3","author":"B Beutler","year":"2003","unstructured":"Beutler B, Rietschel ET (2003) Innate immune sensing and its roots: the story of endotoxin. Nat Rev Immunol 3: 169\u2013176","journal-title":"Nat Rev Immunol"},{"key":"BFEMMM202013591_CR17","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1093\/annonc\/mdu086","volume":"25","author":"D Blum","year":"2014","unstructured":"Blum D, Stene GB, Solheim TS, Fayers P, Hjermstad MJ, Baracos VE, Fearon K, Strasser F, Kaasa S, Block Lieve VD et al (2014) Validation of the Consensus\u2010Definition for Cancer Cachexia and evaluation of a classification model\u2013a study based on data from an international multicentre project (EPCRC\u2010CSA). Ann Oncol 25: 1635\u20131642","journal-title":"Ann Oncol"},{"key":"BFEMMM202013591_CR18","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/ni1001-907","volume":"2","author":"C Bogdan","year":"2001","unstructured":"Bogdan C (2001) Nitric oxide and the immune response. Nat Immunol 2: 907\u2013916","journal-title":"Nat Immunol"},{"key":"BFEMMM202013591_CR19","doi-asserted-by":"crossref","unstructured":"Bonetto A, Rupert JE, Barreto R, Zimmers TA (2016) The Colon\u201026 carcinoma tumor\u2010bearing mouse as a model for the study of cancer cachexia. J Vis Exp e54893","DOI":"10.3791\/54893-v"},{"key":"BFEMMM202013591_CR20","doi-asserted-by":"crossref","first-page":"3572","DOI":"10.1096\/fj.13-230375","volume":"27","author":"TP Braun","year":"2013","unstructured":"Braun TP, Grossberg AJ, Krasnow SM, Levasseur PR, Szumowski M, Zhu XX, Maxson JE, Knoll JG, Barnes AP, Marks DL (2013) Cancer\u2010 and endotoxin\u2010induced cachexia require intact glucocorticoid signaling in skeletal muscle. FASEB J 27: 3572\u20133582","journal-title":"FASEB J"},{"key":"BFEMMM202013591_CR21","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1002\/jcsm.12354","volume":"9","author":"JL Brown","year":"2018","unstructured":"Brown JL, Lee DE, Rosa\u2010Caldwell ME, Brown LA, Perry RA, Haynie WS, Huseman K, Sataranatarajan K, Van Remmen H, Washington TA et al (2018) Protein imbalance in the development of skeletal muscle wasting in tumour\u2010bearing mice. J Cachexia Sarcopenia Muscle 9: 987\u20131002","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"BFEMMM202013591_CR22","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1002\/jcsm.12232","volume":"8","author":"JL Brown","year":"2017","unstructured":"Brown JL, Rosa\u2010Caldwell ME, Lee DE, Blackwell TA, Brown LA, Perry RA, Haynie WS, Hardee JP, Carson JA, Wiggs MP et al (2017) Mitochondrial degeneration precedes the development of muscle atrophy in progression of cancer cachexia in tumour\u2010bearing mice. J Cachexia Sarcopenia Muscle 8: 926\u2013938","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"BFEMMM202013591_CR23","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s10545-006-0320-1","volume":"29","author":"H Brunengraber","year":"2006","unstructured":"Brunengraber H, Roe CR (2006) Anaplerotic molecules: current and future. J Inherit Metab Dis 29: 327\u2013331","journal-title":"J Inherit Metab Dis"},{"key":"BFEMMM202013591_CR24","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1002\/j.1460-2075.1996.tb00524.x","volume":"15","author":"M Buck","year":"1996","unstructured":"Buck M, Chojkier M (1996) Muscle wasting and dedifferentiation induced by oxidative stress in a murine model of cachexia is prevented by inhibitors of nitric oxide synthesis and antioxidants. EMBO J 15: 1753\u20131765","journal-title":"EMBO J"},{"key":"BFEMMM202013591_CR25","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1046\/j.1523-1755.2003.00802.x","volume":"63","author":"PK Chatterjee","year":"2003","unstructured":"Chatterjee PK, Patel NSA, Sivarajah A, Kvale EO, Dugo L, Cuzzocrea S, Brown PAJ, Stewart KN, Mota\u2010Filipe H, Britti D et al (2003) GW274150, a potent and highly selective inhibitor of iNOS, reduces experimental renal ischemia\/reperfusion injury. Kidney Int 63: 853\u2013865","journal-title":"Kidney Int"},{"key":"BFEMMM202013591_CR26","doi-asserted-by":"crossref","first-page":"4305","DOI":"10.1128\/IAI.00578-07","volume":"75","author":"R Chaturvedi","year":"2007","unstructured":"Chaturvedi R, Asim M, Lewis ND, Algood HMS, Cover TL, Kim PY, Wilson KT (2007) L\u2010arginine availability regulates inducible nitric oxide synthase\u2010dependent host defense against Helicobacter pylori. Infect Immun 75: 4305\u20134315","journal-title":"Infect Immun"},{"key":"BFEMMM202013591_CR27","doi-asserted-by":"crossref","first-page":"W486","DOI":"10.1093\/nar\/gky310","volume":"46","author":"J Chong","year":"2018","unstructured":"Chong J, Soufan O, Li C, Caraus I, Li S, Bourque G, Wishart DS, Xia J (2018) MetaboAnalyst 4.0: towards more transparent and integrative metabolomics analysis. Nucleic Acids Res 46: W486\u2013W494","journal-title":"Nucleic Acids Res"},{"key":"BFEMMM202013591_CR28","doi-asserted-by":"crossref","first-page":"e86","DOI":"10.1002\/cpbi.86","volume":"68","author":"J Chong","year":"2019","unstructured":"Chong J, Wishart DS, Xia J (2019a) Using MetaboAnalyst 4.0 for comprehensive and integrative metabolomics data analysis. Curr Protoc Bioinformatics 68: e86","journal-title":"Curr Protoc Bioinformatics"},{"key":"BFEMMM202013591_CR29","doi-asserted-by":"crossref","first-page":"4313","DOI":"10.1093\/bioinformatics\/bty528","volume":"34","author":"J Chong","year":"2018","unstructured":"Chong J, Xia J (2018) MetaboAnalystR: an R package for flexible and reproducible analysis of metabolomics data. Bioinformatics 34: 4313\u20134314","journal-title":"Bioinformatics"},{"key":"BFEMMM202013591_CR30","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3390\/metabo9030057","volume":"9","author":"J Chong","year":"2019","unstructured":"Chong J, Yamamoto M, Xia J (2019b) MetaboAnalystR 2.0: from raw spectra to biological insights. Metabolites 9: 57","journal-title":"Metabolites"},{"key":"BFEMMM202013591_CR31","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.tibs.2016.01.001","volume":"41","author":"S Cogliati","year":"2016","unstructured":"Cogliati S, Enriquez JA, Scorrano L (2016) Mitochondrial cristae: where beauty meets functionality. Trends Biochem Sci 41: 261\u2013273","journal-title":"Trends Biochem Sci"},{"key":"BFEMMM202013591_CR32","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/nrd4467","volume":"14","author":"S Cohen","year":"2015","unstructured":"Cohen S, Nathan JA, Goldberg AL (2015) Muscle wasting in disease: molecular mechanisms and promising therapies. Nat Rev Drug Discovery 14: 58","journal-title":"Nat Rev Drug Discovery"},{"key":"BFEMMM202013591_CR33","first-page":"15","volume":"27","author":"C Constantinou","year":"2011","unstructured":"Constantinou C, Fontes de Oliveira CC, Mintzopoulos D, Busquets S, He J, Kesarwani M, Mindrinos M, Rahme LG, Argiles JM, Tzika AA (2011) Nuclear magnetic resonance in conjunction with functional genomics suggests mitochondrial dysfunction in a murine model of cancer cachexia. Int J Mol Med 27: 15\u201324","journal-title":"Int J Mol Med"},{"key":"BFEMMM202013591_CR34","doi-asserted-by":"crossref","first-page":"8414","DOI":"10.1038\/s41598-018-26625-9","volume":"8","author":"Z Cramer","year":"2018","unstructured":"Cramer Z, Sadek J, Vazquez GG, Di Marco S, Pause A, Pelletier J, Gallouzi I\u2010E (2018) eIF4A inhibition prevents the onset of cytokine\u2010induced muscle wasting by blocking the STAT3 and iNOS pathways. Sci Rep 8: 8414","journal-title":"Sci Rep"},{"key":"BFEMMM202013591_CR35","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13395-018-0188-4","volume":"9","author":"P Cui","year":"2019","unstructured":"Cui P, Shao W, Huang C, Wu CJ, Jiang B, Lin D (2019) Metabolic derangements of skeletal muscle from a murine model of glioma cachexia. Skelet Muscle 9: 3","journal-title":"Skelet Muscle"},{"key":"BFEMMM202013591_CR36","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0014-2999(02)02338-5","volume":"453","author":"S Cuzzocrea","year":"2002","unstructured":"Cuzzocrea S, Chatterjee PK, Mazzon E, McDonald MC, Dugo L, Di Paola R, Serraino I, Britti D, Caputi AP, Thiemermann C (2002) Beneficial effects of GW274150, a novel, potent and selective inhibitor of iNOS activity, in a rodent model of collagen\u2010induced arthritis. Eur J Pharmacol 453: 119\u2013129","journal-title":"Eur J Pharmacol"},{"key":"BFEMMM202013591_CR37","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s13539-012-0101-7","volume":"4","author":"H Der\u2010Torossian","year":"2013","unstructured":"Der\u2010Torossian H, Wysong A, Shadfar S, Willis MS, McDunn J, Couch ME (2013a) Metabolic derangements in the gastrocnemius and the effect of Compound A therapy in a murine model of cancer cachexia. J Cachexia Sarcopenia Muscle 4: 145\u2013155","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"BFEMMM202013591_CR38","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s13539-012-0101-7","volume":"4","author":"H Der\u2010Torossian","year":"2013","unstructured":"Der\u2010Torossian H, Wysong A, Shadfar S, Willis MS, McDunn J, Couch ME (2013b) Metabolic derangements in the gastrocnemius and the effect of Compound A therapy in a murine model of cancer cachexia. J Cachexia Sarcopenia Muscle 4: 145\u2013155","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"BFEMMM202013591_CR39","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1038\/ncomms1899","volume":"3","author":"S Di Marco","year":"2012","unstructured":"Di Marco S, Cammas A, Lian XJ, Kovacs EN, Ma JF, Hall DT, Mazroui R, Richardson J, Pelletier J, Gallouzi IE (2012) The translation inhibitor pateamine A prevents cachexia\u2010induced muscle wasting in mice. Nat Commun 3: 896","journal-title":"Nat Commun"},{"key":"BFEMMM202013591_CR40","doi-asserted-by":"crossref","first-page":"6533","DOI":"10.1128\/MCB.25.15.6533-6545.2005","volume":"25","author":"S Di Marco","year":"2005","unstructured":"Di Marco S, Mazroui R, Dallaire P, Chittur S, Tenenbaum SA, Radzioch D, Marette A, Gallouzi IE (2005) NF\u2010(kappa)B\u2010mediated MyoD decay during muscle wasting requires nitric oxide synthase mRNA stabilization, HuR protein, and nitric oxide release. Mol Cell Biol 25: 6533\u20136545","journal-title":"Mol Cell Biol"},{"key":"BFEMMM202013591_CR41","doi-asserted-by":"crossref","first-page":"4561","DOI":"10.4049\/jimmunol.171.9.4561","volume":"171","author":"S El\u2010Gayar","year":"2003","unstructured":"El\u2010Gayar S, Th\u00fcring\u2010Nahler H, Pfeilschifter J, R\u00f6llinghoff M, Bogdan C (2003) Translational control of inducible nitric oxide synthase by IL\u201013 and arginine availability in inflammatory macrophages. J Immunol 171: 4561\u20134568","journal-title":"J Immunol"},{"key":"BFEMMM202013591_CR42","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1136\/bmj.289.6445.584","volume":"289","author":"PW Emery","year":"1984","unstructured":"Emery PW, Edwards RH, Rennie MJ, Souhami RL, Halliday D (1984) Protein synthesis in muscle measured in vivo in cachectic patients with cancer. Br Med J 289: 584\u2013586","journal-title":"Br Med J"},{"key":"BFEMMM202013591_CR43","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1002\/jcsm.12450","volume":"10","author":"M Erdem","year":"2019","unstructured":"Erdem M, M\u00f6ckel D, Jumpertz S, John C, Fragoulis A, Rudolph I, Wulfmeier J, Springer J, Horn H, Koch M et al (2019) Macrophages protect against loss of adipose tissue during cancer cachexia. J Cachexia Sarcopenia Muscle 10: 1128\u20131142","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"BFEMMM202013591_CR44","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s13539-013-0105-y","volume":"4","author":"J Farkas","year":"2013","unstructured":"Farkas J, von Haehling S, Kalantar\u2010Zadeh K, Morley JE, Anker SD, Lainscak M (2013) Cachexia as a major public health problem: frequent, costly, and deadly. J Cachexia Sarcopenia Muscle 4: 173\u2013178","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"BFEMMM202013591_CR45","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.cmet.2012.06.011","volume":"16","author":"KC Fearon","year":"2012","unstructured":"Fearon KC, Glass DJ, Guttridge DC (2012) Cancer cachexia: mediators, signaling, and metabolic pathways. Cell Metab 16: 153\u2013166","journal-title":"Cell Metab"},{"key":"BFEMMM202013591_CR46","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","volume":"12","author":"K Fearon","year":"2011","unstructured":"Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, Jatoi A, Loprinzi C, MacDonald N, Mantovani G et al (2011) Definition and classification of cancer cachexia: an international consensus. Lancet Oncol 12: 489\u2013495","journal-title":"Lancet Oncol"},{"key":"BFEMMM202013591_CR47","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1113\/expphysiol.2013.072496","volume":"98","author":"C Fermoselle","year":"2013","unstructured":"Fermoselle C, Garcia\u2010Arumi E, Puig\u2010Vilanova E, Andreu AL, Urtreger AJ, de Kier Joffe ED, Tejedor A, Puente\u2010Maestu L, Barreiro E (2013) Mitochondrial dysfunction and therapeutic approaches in respiratory and limb muscles of cancer cachectic mice. Exp Physiol 98: 1349\u20131365","journal-title":"Exp Physiol"},{"key":"BFEMMM202013591_CR48","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1016\/j.bbagen.2012.11.009","volume":"1830","author":"CC Fontes\u2010Oliveira","year":"2013","unstructured":"Fontes\u2010Oliveira CC, Busquets S, Toledo M, Penna F, Aylwin MP, Sirisi S, Silva AP, Orp\u00ed M, Garc\u00eda A, Sette A et al (2013) Mitochondrial and sarcoplasmic reticulum abnormalities in cancer cachexia: altered energetic efficiency? Biochim Biophys Acta 1830: 2770\u20132778","journal-title":"Biochim Biophys Acta"},{"key":"BFEMMM202013591_CR49","doi-asserted-by":"crossref","first-page":"e238","DOI":"10.1200\/JOP.2017.025221","volume":"14","author":"BS Gannavarapu","year":"2018","unstructured":"Gannavarapu BS, Lau SKM, Carter K, Cannon NA, Gao A, Ahn C, Meyer JJ, Sher DJ, Jatoi A, Infante R et al (2018) Prevalence and survival impact of pretreatment cancer\u2010associated weight loss: a tool for guiding early palliative care. J Oncol Pract 14: e238\u2013e250","journal-title":"J Oncol Pract"},{"key":"BFEMMM202013591_CR50","first-page":"1","volume":"8","author":"Z Gao","year":"2017","unstructured":"Gao Z, Li Y, Wang F, Huang T, Fan K, Zhang Yu, Zhong J, Cao Q, Chao T, Jia J et al (2017) Mitochondrial dynamics controls anti\u2010tumour innate immunity by regulating CHIP\u2010IRF1 axis stability. Nat Commun 8: 1\u201313","journal-title":"Nat Commun"},{"key":"BFEMMM202013591_CR51","doi-asserted-by":"crossref","first-page":"80568","DOI":"10.18632\/oncotarget.19631","volume":"8","author":"P Garrido","year":"2017","unstructured":"Garrido P, Shalaby A, Walsh EM, Keane N, Webber M, Keane MM, Sullivan FJ, Kerin MJ, Callagy G, Ryan AE et al (2017) Impact of inducible nitric oxide synthase (iNOS) expression on triple negative breast cancer outcome and activation of EGFR and ERK signaling pathways. Oncotarget 8: 80568\u201380588","journal-title":"Oncotarget"},{"key":"BFEMMM202013591_CR52","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0014-5793(03)00633-1","volume":"546","author":"RW Gilkerson","year":"2003","unstructured":"Gilkerson RW, Selker JM, Capaldi RA (2003) The cristal membrane of mitochondria is the principal site of oxidative phosphorylation. FEBS Lett 546: 355\u2013358","journal-title":"FEBS Lett"},{"key":"BFEMMM202013591_CR53","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/ni.3324","volume":"17","author":"F Ginhoux","year":"2016","unstructured":"Ginhoux F, Schultze JL, Murray PJ, Ochando J, Biswas SK (2016) New insights into the multidimensional concept of macrophage ontogeny, activation and function. Nat Immunol 17: 34\u201340","journal-title":"Nat Immunol"},{"key":"BFEMMM202013591_CR54","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13058-015-0527-x","volume":"17","author":"S Granados\u2010Principal","year":"2015","unstructured":"Granados\u2010Principal S, Liu Yi, Guevara ML, Blanco E, Choi DS, Qian W, Patel T, Rodriguez AA, Cusimano J, Weiss HL et al (2015) Inhibition of iNOS as a novel effective targeted therapy against triple\u2010negative breast cancer. Breast Cancer Res 17: 25","journal-title":"Breast Cancer Res"},{"key":"BFEMMM202013591_CR55","volume":"10","author":"DT Hall","year":"2018","unstructured":"Hall DT, Griss T, Ma JF, Sanchez BJ, Sadek J, Tremblay AMK, Mubaid S, Omer A, Ford RJ, Bedard N et al (2018) The AMPK agonist 5\u2010aminoimidazole\u20104\u2010carboxamide ribonucleotide (AICAR), but not metformin, prevents inflammation\u2010associated cachectic muscle wasting. EMBO Mol Med 10: e8307","journal-title":"EMBO Mol Med"},{"key":"BFEMMM202013591_CR56","doi-asserted-by":"crossref","first-page":"702","DOI":"10.18632\/aging.100358","volume":"3","author":"DT Hall","year":"2011","unstructured":"Hall DT, Ma JF, Marco SD, Gallouzi IE (2011) Inducible nitric oxide synthase (iNOS) in muscle wasting syndrome, sarcopenia, and cachexia. Aging 3: 702\u2013715","journal-title":"Aging"},{"key":"BFEMMM202013591_CR57","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nrm3311","volume":"13","author":"DG Hardie","year":"2012","unstructured":"Hardie DG, Ross FA, Hawley SA (2012) AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nat Rev Mol Cell Biol 13: 251\u2013262","journal-title":"Nat Rev Mol Cell Biol"},{"key":"BFEMMM202013591_CR58","doi-asserted-by":"crossref","first-page":"4821","DOI":"10.1172\/JCI68523","volume":"123","author":"WA He","year":"2013","unstructured":"He WA, Berardi E, Cardillo VM, Acharyya S, Aulino P, Thomas\u2010Ahner J, Wang J, Bloomston M, Muscarella P, Nau P et al (2013) NF\u2010kappaB\u2010mediated Pax7 dysregulation in the muscle microenvironment promotes cancer cachexia. J Clin Invest 123: 4821\u20134835","journal-title":"J Clin Invest"},{"key":"BFEMMM202013591_CR59","volume":"2","author":"AM Heberle","year":"2015","unstructured":"Heberle AM, Prentzell MT, van Eunen K, Bakker BM, Grellscheid SN, Thedieck K (2015) Molecular mechanisms of mTOR regulation by stress. Mol Cell Oncol 2: e970489","journal-title":"Mol Cell Oncol"},{"key":"BFEMMM202013591_CR60","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1096\/fj.14-257717","volume":"29","author":"C Henique","year":"2015","unstructured":"Henique C, Mansouri A, Vavrova E, Lenoir V, Ferry A, Esnous C, Ramond E, Girard J, Bouillaud F, Prip\u2010Buus C et al (2015) Increasing mitochondrial muscle fatty acid oxidation induces skeletal muscle remodeling toward an oxidative phenotype. FASEB J 29: 2473\u20132483","journal-title":"FASEB J"},{"key":"BFEMMM202013591_CR61","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1177\/0333102410370875","volume":"30","author":"HO H\u00f8ivik","year":"2010","unstructured":"H\u00f8ivik HO, Laurijssens BE, Harnisch LO, Twomey CK, Dixon RM, Kirkham AJ, Williams PM, Wentz AL, Lunnon MW (2010) Lack of efficacy of the selective iNOS inhibitor GW274150 in prophylaxis of migraine headache. Cephalalgia 30: 1458\u20131467","journal-title":"Cephalalgia"},{"key":"BFEMMM202013591_CR62","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1002\/cncr.22944","volume":"110","author":"A Jatoi","year":"2007","unstructured":"Jatoi A, Dakhil SR, Nguyen PL, Sloan JA, Kugler JW, Rowland KM, Soori GS, Wender DB, Fitch TR, Novotny PJ et al (2007) A placebo\u2010controlled double blind trial of etanercept for the cancer anorexia\/weight loss syndrome: results from N00C1 from the North Central Cancer Treatment Group. Cancer 110: 1396\u20131403","journal-title":"Cancer"},{"key":"BFEMMM202013591_CR63","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.lungcan.2009.06.020","volume":"68","author":"A Jatoi","year":"2010","unstructured":"Jatoi A, Ritter HL, Dueck A, Nguyen PL, Nikcevich DA, Luyun RF, Mattar BI, Loprinzi CL (2010) A placebo\u2010controlled, double\u2010blind trial of infliximab for cancer\u2010associated weight loss in elderly and\/or poor performance non\u2010small cell lung cancer patients (N01C9). Lung Cancer 68: 234\u2013239","journal-title":"Lung Cancer"},{"key":"BFEMMM202013591_CR64","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1002\/jcb.21060","volume":"100","author":"B Jin","year":"2007","unstructured":"Jin B, Li YP (2007) Curcumin prevents lipopolysaccharide\u2010induced atrogin\u20101\/MAFbx upregulation and muscle mass loss. J Cell Biochem 100: 960\u2013969","journal-title":"J Cell Biochem"},{"key":"BFEMMM202013591_CR65","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s13539-012-0071-9","volume":"3","author":"CM Julienne","year":"2012","unstructured":"Julienne CM, Dumas JF, Goupille C, Pinault M, Berri C, Collin A, Tesseraud S, Couet C, Servais S (2012) Cancer cachexia is associated with a decrease in skeletal muscle mitochondrial oxidative capacities without alteration of ATP production efficiency. J Cachexia Sarcopenia Muscle 3: 265\u2013275","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"BFEMMM202013591_CR66","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/sj.bjc.6606034","volume":"104","author":"V Kostourou","year":"2011","unstructured":"Kostourou V, Cartwright JE, Johnstone AP, Boult JK, Cullis ER, Whitley G, Robinson SP (2011) The role of tumour\u2010derived iNOS in tumour progression and angiogenesis. Br J Cancer 104: 83\u201390","journal-title":"Br J Cancer"},{"key":"BFEMMM202013591_CR67","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/jcsm.12498","volume":"11","author":"T Kunzke","year":"2019","unstructured":"Kunzke T, Buck A, Prade VM, Feuchtinger A, Prokopchuk O, Martignoni ME, Heisz S, Hauner H, Janssen K\u2010P, Walch A et al (2019) Derangements of amino acids in cachectic skeletal muscle are caused by mitochondrial dysfunction. J Cachexia Sarcopenia Muscle 11: 226\u2013240","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"BFEMMM202013591_CR68","doi-asserted-by":"crossref","first-page":"E852","DOI":"10.1152\/ajpendo.00526.2018","volume":"316","author":"JH Lautaoja","year":"2019","unstructured":"Lautaoja JH, Lalowski M, Nissinen TA, Hentila J, Shi Y, Ritvos O, Cheng S, Hulmi JJ (2019a) Muscle and serum metabolomes are dysregulated in colon\u201026 tumor\u2010bearing mice despite amelioration of cachexia with activin receptor type 2B ligand blockade. Am J Physiol Endocrinol Metab 316: E852\u2013E865","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"BFEMMM202013591_CR69","doi-asserted-by":"crossref","first-page":"E852","DOI":"10.1152\/ajpendo.00526.2018","volume":"316","author":"JH Lautaoja","year":"2019","unstructured":"Lautaoja JH, Lalowski M, Nissinen TA, Hentil\u00e4 J, Shi Y, Ritvos O, Cheng S, Hulmi JJ (2019b) Muscle and serum metabolomes are dysregulated in colon\u201026 tumor\u2010bearing mice despite amelioration of cachexia with activin receptor type 2B ligand blockade. Am J Physiol Endocrinol Metab 316: E852\u2013E865","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"BFEMMM202013591_CR70","doi-asserted-by":"crossref","first-page":"4843","DOI":"10.1073\/pnas.0735876100","volume":"100","author":"J Lee","year":"2003","unstructured":"Lee J, Ryu H, Ferrante RJ, Morris SM, Ratan RR (2003) Translational control of inducible nitric oxide synthase expression by arginine can explain the arginine paradox. Proc Natl Acad Sci 100: 4843\u20134848","journal-title":"Proc Natl Acad Sci"},{"key":"BFEMMM202013591_CR71","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3390\/metabo9020036","volume":"9","author":"S Li","year":"2019","unstructured":"Li S, Gao D, Jiang Y (2019) Function, detection and alteration of acylcarnitine metabolism in hepatocellular carcinoma. Metabolites 9: 36","journal-title":"Metabolites"},{"key":"BFEMMM202013591_CR72","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.7150\/thno.40495","volume":"10","author":"Y Li","year":"2020","unstructured":"Li Y, He Y, Miao K, Zheng Y, Deng C, Liu T\u2010M (2020) Imaging of macrophage mitochondria dynamics in vivo reveals cellular activation phenotype for diagnosis. Theranostics 10: 2897","journal-title":"Theranostics"},{"key":"BFEMMM202013591_CR73","doi-asserted-by":"crossref","first-page":"622","DOI":"10.15252\/emmm.201607052","volume":"9","author":"JF Ma","year":"2017","unstructured":"Ma JF, Sanchez BJ, Hall DT, Tremblay AK, Di Marco S, Gallouzi IE (2017) STAT3 promotes IFNgamma\/TNFalpha\u2010induced muscle wasting in an NF\u2010kappaB\u2010dependent and IL\u20106\u2010independent manner. EMBO Mol Med 9: 622\u2013637","journal-title":"EMBO Mol Med"},{"key":"BFEMMM202013591_CR74","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/2049-3002-1-22","volume":"1","author":"S McGuirk","year":"2013","unstructured":"McGuirk S, Gravel SP, Deblois G, Papadopoli DJ, Faubert B, Wegner A, Hiller K, Avizonis D, Akavia UD, Jones RG et al (2013) PGC\u20101alpha supports glutamine metabolism in breast cancer. Cancer Metab 1: 22","journal-title":"Cancer Metab"},{"key":"BFEMMM202013591_CR75","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3389\/fphys.2014.00503","volume":"5","author":"JB McLean","year":"2014","unstructured":"McLean JB, Moylan JS, Andrade FH (2014) Mitochondria dysfunction in lung cancer\u2010induced muscle wasting in C2C12 myotubes. Front Physiol 5: 503","journal-title":"Front Physiol"},{"key":"BFEMMM202013591_CR76","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/jcsm.12225","volume":"8","author":"KA Michaelis","year":"2017","unstructured":"Michaelis KA, Zhu X, Burfeind KG, Krasnow SM, Levasseur PR, Morgan TK, Marks DL (2017) Establishment and characterization of a novel murine model of pancreatic cancer cachexia. J Cachexia Sarcopenia Muscle 8: 824\u2013838","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"BFEMMM202013591_CR77","doi-asserted-by":"crossref","first-page":"7189","DOI":"10.1074\/jbc.M116.774471","volume":"292","author":"SA Mookerjee","year":"2017","unstructured":"Mookerjee SA, Gerencser AA, Nicholls DG, Brand MD (2017) Quantifying intracellular rates of glycolytic and oxidative ATP production and consumption using extracellular flux measurements. J Biol Chem 292: 7189\u20137207","journal-title":"J Biol Chem"},{"key":"BFEMMM202013591_CR78","doi-asserted-by":"crossref","first-page":"12649","DOI":"10.1074\/jbc.AAC118.004855","volume":"293","author":"SA Mookerjee","year":"2018","unstructured":"Mookerjee SA, Gerencser AA, Nicholls DG, Brand MD (2018) Quantifying intracellular rates of glycolytic and oxidative ATP production and consumption using extracellular flux measurements. J Biol Chem 293: 12649\u201312652","journal-title":"J Biol Chem"},{"key":"BFEMMM202013591_CR79","doi-asserted-by":"crossref","first-page":"17261","DOI":"10.1073\/pnas.1905172116","volume":"116","author":"S Mubaid","year":"2019","unstructured":"Mubaid S, Ma JF, Omer A, Ashour K, Lian XJ, Sanchez BJ, Robinson S, Cammas A, Dormoy\u2010Raclet V, Di Marco S et al (2019) HuR counteracts miR\u2010330 to promote STAT3 translation during inflammation\u2010induced muscle wasting. Proc Natl Acad Sci 116: 17261\u201317270","journal-title":"Proc Natl Acad Sci"},{"key":"BFEMMM202013591_CR80","first-page":"533","volume":"5","author":"KT Murphy","year":"2012","unstructured":"Murphy KT, Chee A, Trieu J, Naim T, Lynch GS (2012) Importance of functional and metabolic impairments in the characterization of the C\u201026 murine model of cancer cachexia. Dis Model Mech. 5: 533\u2013545","journal-title":"Dis Model Mech."},{"key":"BFEMMM202013591_CR81","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1038\/bjc.2011.391","volume":"105","author":"RA Murphy","year":"2011","unstructured":"Murphy RA, Yeung E, Mazurak VC, Mourtzakis M (2011) Influence of eicosapentaenoic acid supplementation on lean body mass in cancer cachexia. Br J Cancer 105: 1469\u20131473","journal-title":"Br J Cancer"},{"key":"BFEMMM202013591_CR82","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1186\/s12885-017-3795-2","volume":"17","author":"T Naito","year":"2017","unstructured":"Naito T, Okayama T, Aoyama T, Ohashi T, Masuda Y, Kimura M, Shiozaki H, Murakami H, Kenmotsu H, Taira T et al (2017) Unfavorable impact of cancer cachexia on activity of daily living and need for inpatient care in elderly patients with advanced non\u2010small\u2010cell lung cancer in Japan: a prospective longitudinal observational study. BMC Cancer 17: 800","journal-title":"BMC Cancer"},{"key":"BFEMMM202013591_CR83","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s11010-007-9451-4","volume":"303","author":"L Nanetti","year":"2007","unstructured":"Nanetti L, Taffi R, Vignini A, Moroni C, Raffaelli F, Bacchetti T, Silvestrini M, Provinciali L, Mazzanti L (2007) Reactive oxygen species plasmatic levels in ischemic stroke. Mol Cell Biochem 303: 19\u201325","journal-title":"Mol Cell Biochem"},{"key":"BFEMMM202013591_CR84","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/SPC.0000000000000091","volume":"8","author":"AA Narsale","year":"2014","unstructured":"Narsale AA, Carson JA (2014) Role of IL\u20106 in cachexia\u2013therapeutic implications. Curr Opin Support Palliat Care 8: 321","journal-title":"Curr Opin Support Palliat Care"},{"key":"BFEMMM202013591_CR85","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/j.biocel.2013.04.014","volume":"45","author":"AI Padr\u00e3o","year":"2013","unstructured":"Padr\u00e3o AI, Oliveira P, Vitorino R, Cola\u00e7o B, Pires MJ, M\u00e1rquez M, Castellanos E, Neuparth MJ, Teixeira C, Costa C et al (2013) Bladder cancer\u2010induced skeletal muscle wasting: disclosing the role of mitochondria plasticity. Int J Biochem Cell Biol 45: 1399\u20131409","journal-title":"Int J Biochem Cell Biol"},{"key":"BFEMMM202013591_CR86","first-page":"1","volume":"11","author":"EM Palmieri","year":"2020","unstructured":"Palmieri EM, Gonzalez\u2010Cotto M, Baseler WA, Davies LC, Ghesqui\u00e8re B, Maio N, Rice CM, Rouault TA, Cassel T, Higashi RM et al (2020) Nitric oxide orchestrates metabolic rewiring in M1 macrophages by targeting aconitase 2 and pyruvate dehydrogenase. Nat Commun 11: 1\u201317","journal-title":"Nat Commun"},{"key":"BFEMMM202013591_CR87","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.devcel.2018.05.026","volume":"45","author":"P Parajuli","year":"2018","unstructured":"Parajuli P, Kumar S, Loumaye A, Singh P, Eragamreddy S, Nguyen TL, Ozkan S, Razzaque MS, Prunier C, Thissen J\u2010P et al (2018) Twist1 activation in muscle progenitor cells causes muscle loss akin to cancer cachexia. Dev Cell 45: 712\u2013725","journal-title":"Dev Cell"},{"key":"BFEMMM202013591_CR88","doi-asserted-by":"crossref","first-page":"730","DOI":"10.3945\/an.115.011387","volume":"7","author":"M Pfeuffer","year":"2016","unstructured":"Pfeuffer M, Jaudszus A (2016) Pentadecanoic and heptadecanoic acids: multifaceted odd\u2010chain fatty acids. Adv Nutr 7: 730\u2013734","journal-title":"Adv Nutr"},{"key":"BFEMMM202013591_CR89","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/jcsm.12360","volume":"10","author":"F Pin","year":"2019","unstructured":"Pin F, Barreto R, Couch ME, Bonetto A, O'Connell TM (2019a) Cachexia induced by cancer and chemotherapy yield distinct perturbations to energy metabolism. J Cachexia Sarcopenia Muscle 10: 140\u2013154","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"BFEMMM202013591_CR90","doi-asserted-by":"crossref","first-page":"7778","DOI":"10.1096\/fj.201802799R","volume":"33","author":"F Pin","year":"2019","unstructured":"Pin F, Novinger LJ, Huot JR, Harris RA, Couch ME, O'Connell TM, Bonetto A (2019b) PDK4 drives metabolic alterations and muscle atrophy in cancer cachexia. FASEB J 33: 7778\u20137790","journal-title":"FASEB J"},{"key":"BFEMMM202013591_CR91","doi-asserted-by":"crossref","first-page":"e200","DOI":"10.1038\/oncsis.2016.3","volume":"5","author":"PE Porporato","year":"2016","unstructured":"Porporato PE (2016) Understanding cachexia as a cancer metabolism syndrome. Oncogenesis 5: e200","journal-title":"Oncogenesis"},{"key":"BFEMMM202013591_CR92","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1096\/fj.13-240580","volume":"28","author":"MJ Puppa","year":"2014","unstructured":"Puppa MJ, Gao S, Narsale AA, Carson JA (2014) Skeletal muscle glycoprotein 130's role in Lewis lung carcinoma\u2010induced cachexia. FASEB J 28: 998\u20131009","journal-title":"FASEB J"},{"key":"BFEMMM202013591_CR93","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s13539-011-0047-1","volume":"3","author":"MJ Puppa","year":"2012","unstructured":"Puppa MJ, White JP, Velazquez KT, Baltgalvis KA, Sato S, Baynes JW, Carson JA (2012) The effect of exercise on IL\u20106\u2010induced cachexia in the Apc ( Min\/+) mouse. J Cachexia Sarcopenia Muscle 3: 117\u2013137","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"BFEMMM202013591_CR94","doi-asserted-by":"crossref","first-page":"92438","DOI":"10.1039\/C5RA19004E","volume":"5","author":"Y QuanJun","year":"2015","unstructured":"QuanJun Y, GenJin Y, LiLi W, Yan H, YongLong H, Jin L, Jie L, JinLu H, Cheng G (2015) Integrated analysis of serum and intact muscle metabonomics identify metabolic profiles of cancer cachexia in a dynamic mouse model. RSC Adv 5: 92438\u201392448","journal-title":"RSC Adv"},{"key":"BFEMMM202013591_CR95","doi-asserted-by":"crossref","first-page":"E392","DOI":"10.1152\/ajpendo.90529.2008","volume":"297","author":"S Ramamoorthy","year":"2009","unstructured":"Ramamoorthy S, Donohue M, Buck M (2009) Decreased Jun\u2010D and myogenin expression in muscle wasting of human cachexia. Am J Physiol Endocrinol Metab 297: E392\u2013E401","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"BFEMMM202013591_CR96","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","volume":"9","author":"CA Schneider","year":"2012","unstructured":"Schneider CA, Rasband WS, Eliceiri KW (2012) NIH Image to ImageJ: 25 years of image analysis. Nat Methods 9: 671\u2013675","journal-title":"Nat Methods"},{"key":"BFEMMM202013591_CR97","doi-asserted-by":"crossref","first-page":"R712","DOI":"10.1152\/ajpregu.00229.2011","volume":"302","author":"RA Schuh","year":"2012","unstructured":"Schuh RA, Jackson KC, Khairallah RJ, Ward CW, Spangenburg EE (2012) Measuring mitochondrial respiration in intact single muscle fibers. Am J Physiol Regul Integr Comp Physiol 302: R712\u2013R719","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"BFEMMM202013591_CR98","first-page":"254","volume":"30","author":"M Seymour","year":"2012","unstructured":"Seymour M, P\u00e9tavy F, Chiesa F, Perry H, Lukey P, Binks M, Donatien P, Freidin A, Eckersley R, McClinton C (2012) Ultrasonographic measures of synovitis in an early phase clinical trial: a double\u2010blind, randomised, placebo and comparator controlled phase IIa clinical trial of GW274150 (a selective inducible nitric oxide synthase inhibitor) in rheumatoid arthritis. Clin Exp Rheumatol Incl Suppl 30: 254","journal-title":"Clin Exp Rheumatol Incl Suppl"},{"key":"BFEMMM202013591_CR99","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.canlet.2020.04.017","volume":"484","author":"SK Shukla","year":"2020","unstructured":"Shukla SK, Markov SD, Attri KS, Vernucci E, King RJ, Dasgupta A, Grandgenett PM, Hollingsworth MA, Singh PK, Yu F et al (2020) Macrophages potentiate STAT3 signaling in skeletal muscles and regulate pancreatic cancer cachexia. Cancer Lett 484: 29\u201339","journal-title":"Cancer Lett"},{"key":"BFEMMM202013591_CR100","doi-asserted-by":"crossref","first-page":"133","DOI":"10.18632\/aging.100436","volume":"4","author":"AM Shum","year":"2012","unstructured":"Shum AM, Mahendradatta T, Taylor RJ, Painter AB, Moore MM, Tsoli M, Tan TC, Clarke SJ, Robertson GR, Polly P (2012) Disruption of MEF2C signaling and loss of sarcomeric and mitochondrial integrity in cancer\u2010induced skeletal muscle wasting. Aging 4: 133\u2013143","journal-title":"Aging"},{"key":"BFEMMM202013591_CR101","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/bjc.1993.126","volume":"67","author":"KL Smith","year":"1993","unstructured":"Smith KL, Tisdale MJ (1993) Increased protein degradation and decreased protein synthesis in skeletal muscle during cancer cachexia. Br J Cancer 67: 680\u2013685","journal-title":"Br J Cancer"},{"key":"BFEMMM202013591_CR102","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s11764-009-0110-5","volume":"4","author":"RM Speck","year":"2010","unstructured":"Speck RM, Courneya KS, M\u00e2sse LC, Duval S, Schmitz KH (2010) An update of controlled physical activity trials in cancer survivors: a systematic review and meta\u2010analysis. J Cancer Surviv 4: 87\u2013100","journal-title":"J Cancer Surviv"},{"issue":"Pt 3","key":"BFEMMM202013591_CR103","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1042\/bj3450437","volume":"345","author":"SC Stein","year":"2000","unstructured":"Stein SC, Woods A, Jones NA, Davison MD, Carling D (2000) The regulation of AMP\u2010activated protein kinase by phosphorylation. Biochem J 345(Pt 3): 437\u2013443","journal-title":"Biochem J"},{"key":"BFEMMM202013591_CR104","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.critrevonc.2013.07.001","volume":"88","author":"GB Stene","year":"2013","unstructured":"Stene GB, Helbostad J, Balstad TR, Riphagen II, Kaasa S, Oldervoll LM (2013) Effect of physical exercise on muscle mass and strength in cancer patients during treatment\u2014a systematic review. Crit Rev Oncol Hematol 88: 573\u2013593","journal-title":"Crit Rev Oncol Hematol"},{"key":"BFEMMM202013591_CR105","first-page":"303","volume":"20","author":"H Strijdom","year":"2009","unstructured":"Strijdom H, Chamane N, Lochner A (2009) Nitric oxide in the cardiovascular system: a simple molecule with complex actions. Cardiovasc J Afr 20: 303\u2013310","journal-title":"Cardiovasc J Afr"},{"key":"BFEMMM202013591_CR106","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/nrd2222","volume":"6","author":"C Szabo","year":"2007","unstructured":"Szabo C, Ischiropoulos H, Radi R (2007) Peroxynitrite: biochemistry, pathophysiology and development of therapeutics. Nat Rev Drug Discov 6: 662\u2013680","journal-title":"Nat Rev Drug Discov"},{"key":"BFEMMM202013591_CR107","first-page":"3473","volume":"24","author":"K Takayama","year":"2016","unstructured":"Takayama K, Atagi S, Imamura F, Tanaka H, Minato K, Harada T, Katakami N, Yokoyama T, Yoshimori K, Takiguchi Y et al (2016) Quality of life and survival survey of cancer cachexia in advanced non\u2010small cell lung cancer patients\u2010Japan nutrition and QOL survey in patients with advanced non\u2010small cell lung cancer study. Support Care Cancer 24: 3473\u20133480","journal-title":"Support Care Cancer"},{"key":"BFEMMM202013591_CR108","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.abb.2003.08.013","volume":"419","author":"PJ Thornalley","year":"2003","unstructured":"Thornalley PJ (2003) Use of aminoguanidine (Pimagedine) to prevent the formation of advanced glycation endproducts. Arch Biochem Biophys 419: 31\u201340","journal-title":"Arch Biochem Biophys"},{"key":"BFEMMM202013591_CR109","doi-asserted-by":"crossref","first-page":"djv274","DOI":"10.1093\/jnci\/djv274","volume":"107","author":"Y\u2010C Tseng","year":"2015","unstructured":"Tseng Y\u2010C, Kulp SK, Lai I\u2010L, Hsu E\u2010C, He WA, Frankhouser DE, Yan PS, Mo X, Bloomston M, Lesinski GB et al (2015a) Preclinical investigation of the novel histone deacetylase inhibitor AR\u201042 in the treatment of cancer\u2010induced cachexia. J Natl Cancer Inst 107: djv274","journal-title":"J Natl Cancer Inst"},{"key":"BFEMMM202013591_CR110","doi-asserted-by":"crossref","first-page":"djv274","DOI":"10.1093\/jnci\/djv274","volume":"107","author":"YC Tseng","year":"2015","unstructured":"Tseng YC, Kulp SK, Lai IL, Hsu EC, He WA, Frankhouser DE, Yan PS, Mo X, Bloomston M, Lesinski GB et al (2015b) Preclinical Investigation of the Novel Histone Deacetylase Inhibitor AR\u201042 in the Treatment of Cancer\u2010Induced Cachexia. J Natl Cancer Inst 107: djv274","journal-title":"J Natl Cancer Inst"},{"key":"BFEMMM202013591_CR111","doi-asserted-by":"crossref","first-page":"886","DOI":"10.3892\/ijo.2013.1998","volume":"43","author":"AA Tzika","year":"2013","unstructured":"Tzika AA, Fontes\u2010oliveira CC, Shestov AA, Constantinou C, Psychogios N, Righi V, Mintzopoulos D, Busquets S, Lopez\u2010soriano FJ, Milot S et al (2013) Skeletal muscle mitochondrial uncoupling in a murine cancer cachexia model. Int J Oncol 43: 886\u2013894","journal-title":"Int J Oncol"},{"key":"BFEMMM202013591_CR112","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1113\/EP087429","volume":"104","author":"BN VanderVeen","year":"2019","unstructured":"VanderVeen BN, Fix DK, Montalvo RN, Counts BR, Smuder AJ, Murphy EA, Koh HJ, Carson JA (2019) The regulation of skeletal muscle fatigability and mitochondrial function by chronically elevated interleukin\u20106. Exp Physiol 104: 385\u2013397","journal-title":"Exp Physiol"},{"key":"BFEMMM202013591_CR113","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1152\/japplphysiol.00897.2017","volume":"124","author":"BN VanderVeen","year":"2018","unstructured":"VanderVeen BN, Hardee JP, Fix DK, Carson JA (2018) Skeletal muscle function during the progression of cancer cachexia in the male Apc(Min\/+) mouse. J Appl Physiol 124: 684\u2013695","journal-title":"J Appl Physiol"},{"key":"BFEMMM202013591_CR114","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/j.clnu.2016.09.008","volume":"36","author":"AAL Vigano","year":"2017","unstructured":"Vigano AAL, Morais JA, Ciutto L, Rosenthall L, di Tomasso J, Khan S, Olders H, Borod M, Kilgour RD (2017) Use of routinely available clinical, nutritional, and functional criteria to classify cachexia in advanced cancer patients. Clin Nutr 36: 1378\u20131390","journal-title":"Clin Nutr"},{"key":"BFEMMM202013591_CR115","doi-asserted-by":"crossref","unstructured":"Vitecek J, Lojek A, Valacchi G, Kubala L (2012) Arginine\u2010based inhibitors of nitric oxide synthase: therapeutic potential and challenges. Mediators Inflamm 2012318087","DOI":"10.1155\/2012\/318087"},{"key":"BFEMMM202013591_CR116","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s11011-014-9543-2","volume":"30","author":"D Wei","year":"2015","unstructured":"Wei D, Xiong X, Zhao H (2015) Tim\u20103 cell signaling and iNOS are involved in the protective effects of ischemic postconditioning against focal ischemia in rats. Metab Brain Dis 30: 483\u2013490","journal-title":"Metab Brain Dis"},{"key":"BFEMMM202013591_CR117","doi-asserted-by":"crossref","first-page":"e24650","DOI":"10.1371\/journal.pone.0024650","volume":"6","author":"JP White","year":"2011","unstructured":"White JP, Baynes JW, Welle SL, Kostek MC, Matesic LE, Sato S, Carson JA (2011) The regulation of skeletal muscle protein turnover during the progression of cancer cachexia in the Apc(Min\/+) mouse. PLoS One 6: e24650","journal-title":"PLoS One"},{"key":"BFEMMM202013591_CR118","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/2044-5040-2-14","volume":"2","author":"JP White","year":"2012","unstructured":"White JP, Puppa MJ, Sato S, Gao S, Price RL, Baynes JW, Kostek MC, Matesic LE, Carson JA (2012) IL\u20106 regulation on skeletal muscle mitochondrial remodeling during cancer cachexia in the ApcMin\/+ mouse. Skelet Muscle 2: 14","journal-title":"Skelet Muscle"},{"key":"BFEMMM202013591_CR119","doi-asserted-by":"crossref","first-page":"E1042","DOI":"10.1152\/ajpendo.00410.2012","volume":"304","author":"JP White","year":"2013","unstructured":"White JP, Puppa MJ, Gao S, Sato S, Welle SL, Carson JA (2013) Muscle mTORC1 suppression by IL\u20106 during cancer cachexia: a role for AMPK. Am J Physiol Endocrinol Metab 304: E1042\u20131052","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"BFEMMM202013591_CR120","first-page":"18","volume":"6","author":"B Wiedenmann","year":"2008","unstructured":"Wiedenmann B, Malfertheiner P, Friess H, Ritch P, Arseneau J, Mantovani G, Caprioni F, Van Cutsem E, Richel D, DeWitte M et al (2008) A multicenter, phase II study of infliximab plus gemcitabine in pancreatic cancer cachexia. J Support Oncol 6: 18\u201325","journal-title":"J Support Oncol"},{"key":"BFEMMM202013591_CR121","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2174\/157339912800840514","volume":"8","author":"DA Wiseman","year":"2012","unstructured":"Wiseman DA, Thurmond DC (2012) The good and bad effects of cysteine S\u2010nitrosylation and tyrosine nitration upon insulin exocytosis: a balancing act. Curr Diabetes Rev 8: 303\u2013315","journal-title":"Curr Diabetes Rev"},{"key":"BFEMMM202013591_CR122","doi-asserted-by":"crossref","first-page":"42710","DOI":"10.1038\/srep42710","volume":"7","author":"T Wu","year":"2017","unstructured":"Wu T, Zheng X, Yang M, Zhao A, Li M, Chen T, Panee J, Jia W, Ji G (2017) Serum lipid alterations identified in chronic hepatitis B, hepatitis B virus\u2010associated cirrhosis and carcinoma patients. Sci Rep 7: 42710","journal-title":"Sci Rep"},{"key":"BFEMMM202013591_CR123","doi-asserted-by":"crossref","first-page":"W127","DOI":"10.1093\/nar\/gks374","volume":"40","author":"J Xia","year":"2012","unstructured":"Xia J, Mandal R, Sinelnikov IV, Broadhurst D, Wishart DS (2012) MetaboAnalyst 2.0\u2014a comprehensive server for metabolomic data analysis. Nucleic Acids Res 40: W127\u2013W133","journal-title":"Nucleic Acids Res"},{"key":"BFEMMM202013591_CR124","doi-asserted-by":"crossref","first-page":"W652","DOI":"10.1093\/nar\/gkp356","volume":"37","author":"J Xia","year":"2009","unstructured":"Xia J, Psychogios N, Young N, Wishart DS (2009) MetaboAnalyst: a web server for metabolomic data analysis and interpretation. Nucleic Acids Res 37: W652\u2013W660","journal-title":"Nucleic Acids Res"},{"key":"BFEMMM202013591_CR125","doi-asserted-by":"crossref","first-page":"W251","DOI":"10.1093\/nar\/gkv380","volume":"43","author":"J Xia","year":"2015","unstructured":"Xia J, Sinelnikov IV, Han B, Wishart DS (2015) MetaboAnalyst 3.0\u2014making metabolomics more meaningful. Nucleic Acids Res 43: W251\u2013W257","journal-title":"Nucleic Acids Res"},{"key":"BFEMMM202013591_CR126","first-page":"14.10.11\u201014.10.","volume":"34","author":"J Xia","year":"2011","unstructured":"Xia J, Wishart DS (2011a) Metabolomic data processing, analysis, and interpretation using MetaboAnalyst. Curr Protoc Bioinformat 34: 14.10.11\u201014.10.48","journal-title":"Curr Protoc Bioinformat"},{"key":"BFEMMM202013591_CR127","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/nprot.2011.319","volume":"6","author":"J Xia","year":"2011","unstructured":"Xia J, Wishart DS (2011b) Web\u2010based inference of biological patterns, functions and pathways from metabolomic data using MetaboAnalyst. Nat Protoc 6: 743\u2013760","journal-title":"Nat Protoc"},{"key":"BFEMMM202013591_CR128","first-page":"14.10.11\u201014.10.","volume":"55","author":"J Xia","year":"2016","unstructured":"Xia J, Wishart DS (2016) Using MetaboAnalyst 3.0 for comprehensive metabolomics data analysis. Curr Protoc Bioinformat 55: 14.10.11\u201014.10.91","journal-title":"Curr Protoc Bioinformat"},{"key":"BFEMMM202013591_CR129","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1172\/JCI82925","volume":"126","author":"W Xu","year":"2016","unstructured":"Xu W, Ghosh S, Comhair SAA, Asosingh K, Janocha AJ, Mavrakis DA, Bennett CD, Gruca LL, Graham BB, Queisser KA et al (2016) Increased mitochondrial arginine metabolism supports bioenergetics in asthma. J Clin Investig 126: 2465\u20132481","journal-title":"J Clin Investig"},{"key":"BFEMMM202013591_CR130","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00216-012-5782-4","volume":"403","author":"L Zhou","year":"2012","unstructured":"Zhou L, Wang Q, Yin P, Xing W, Wu Z, Chen S, Lu X, Zhang Y, Lin X, Xu G (2012) Serum metabolomics reveals the deregulation of fatty acids metabolism in hepatocellular carcinoma and chronic liver diseases. Anal Bioanal Chem 403: 203\u2013213","journal-title":"Anal Bioanal Chem"},{"key":"BFEMMM202013591_CR131","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/jcsm.12275","volume":"9","author":"T Zhou","year":"2018","unstructured":"Zhou T, Wang B, Liu H, Yang K, Thapa S, Zhang H, Li L, Yu S (2018) Development and validation of a clinically applicable score to classify cachexia stages in advanced cancer patients. J Cachexia Sarcopenia Muscle 9: 306\u2013314","journal-title":"J Cachexia Sarcopenia Muscle"}],"container-title":["EMBO Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.15252\/emmm.202013591.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.15252\/emmm.202013591","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.15252\/emmm.202013591\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.embopress.org\/doi\/pdf\/10.15252\/emmm.202013591","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.15252\/emmm.202013591.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T06:41:45Z","timestamp":1779086505000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.15252\/emmm.202013591"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,7]]},"references-count":131,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7,7]]}},"alternative-id":["BFEMMM202013591"],"URL":"https:\/\/doi.org\/10.15252\/emmm.202013591","relation":{},"ISSN":["1757-4676","1757-4684"],"issn-type":[{"value":"1757-4676","type":"print"},{"value":"1757-4684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,7]]},"assertion":[{"value":"14 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"EMMM202013591"}}